Advancing AI-Powered Eye Health Innovation
MyEyesAI is proud to announce its selection into the 8-Week Core Program at C10 Labs — a premier AI venture studio and accelerator focused on building category-defining AI-first companies.
As part of this cohort, MyEyesAI will participate in the program culminating in the C10 Labs NYC Demo Day, where leading AI startups showcase their innovations to investors, healthcare leaders, and the broader applied AI ecosystem.
About the C10 Labs NYC Program
C10 Labs is an AI-native venture studio and fund born out of the MIT ecosystem, dedicated to transforming frontier research into real-world companies solving complex global challenges. The organization supports founders through structured accelerator programs, expert mentorship, technical guidance, and access to an extensive investor and industry network.
The NYC cohort is part of a broader initiative helping AI startups scale applied AI solutions across industries including healthcare, biotech, robotics, and advanced manufacturing.
Participation in the Core Program provides startups with:
- Strategic venture development support
- Product-market fit validation
- AI architecture and governance guidance
- Access to domain experts, operators, and investors
- Preparation for venture funding and commercialization
Why This Matters for MyEyesAI
Being selected into the C10 Labs Core Program represents an important milestone in MyEyesAI’s mission to transform eye care through artificial intelligence.
MyEyesAI is designed to detect and analyze a broad spectrum of eye conditions, enabling earlier diagnosis, scalable screening, and improved clinical decision support across healthcare systems worldwide.
Through the program, MyEyesAI will accelerate:
- Clinical AI model advancement
- Real-world healthcare deployment readiness
- Strategic partnerships in the U.S. AI ecosystem
- Investor engagement and global expansion
Preparing for Demo Day
At the end of the 8-week program, MyEyesAI will present at C10 Labs NYC Demo Day, showcasing its platform to:
- Venture capital investors
- Health system leaders
- AI researchers and operators
- Strategic healthcare partners
Demo Day represents a pivotal opportunity to demonstrate how AI can expand access to comprehensive eye disease detection — moving beyond single-condition screening toward holistic vision intelligence.
Building the Future of AI-Driven Eye Health
MyEyesAI joins a community of founders building applied AI solutions designed to move innovation from research environments into real-world impact.
This collaboration strengthens MyEyesAI’s commitment to:
- Responsible medical AI development
- Clinical safety and validation
- Scalable population eye health solutions
- Global accessibility to vision care
Meet Us at Demo Day
We look forward to connecting with investors, healthcare innovators, and partners at the upcoming C10 Labs NYC Demo Day.
👉 Interested in learning more or collaborating?
Contact MyEyesAI to schedule a conversation.